Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product. The genetic code stored in DNA can be studied using gene expression and the properties of the expression determine the phenotype of the organism.
Gene sequencing helps in understanding the metabolic pathways in an organism and how a disease affects a cell (pathogenesis). The genome-wide study can be used to correctly categorize diseases. This has led to its improved use in various uses such as pharmacogenomics, diagnostics, toxicology, and biomarkers.
Global Gene Expression Analysis Market-Market Dynamics
The report details several factors driving and restraining the market. Some of these are listed below.
Some of the factors contributing to the growth of the market are:
Rapid technological advances
Development of genomic databases
Increased government funding towards genomics
Increased levels of health awareness among population
Use of gene expression analysis in healthcare institutions and hospitals
The market is highly constrained due to:
Lack of skilled labor
High cost of instruments
Capitalization on patents
The global gene expression analysis market can be segmented by technology: PCR, NGS, microarray, sanger sequencing, and others; usage: reagents, kits, and instruments; services: bioinformatics, data analysis, gene expression analysis, and others; and application: drug discovery, biotechnology, academic labs, diagnostic labs, and others.
The global gene expression analysis market has also been geographically segmented into Asia-Pacific, Europe, Middle East and North Africa (MENA), North America and Rest of the World, with North America dominating the global market. Asia-Pacific is also an emerging market which has a scope for growth and can potentially dominate the market in the future.
Market analysis for the gene expression analysis market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the gene expression analysis market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Characterization
5.1 Current Market Scenario
5.2 Market Overview
5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis
5.3.1 Market Drivers
184.108.40.206 Rapid Technological Advances
220.127.116.11 Development of Genomic Databases
18.104.22.168 Increased Government Funding towards Genomics
5.3.2 Market Restraints
22.214.171.124 Lack of Skilled Labor
126.96.36.199 High Cost of Instruments
5.3.3 Market Challenges
188.8.131.52 Capitalization on Patents
5.3.4 Market Opportunities
184.108.40.206 Increased Level of Health Awareness among Population
220.127.116.11 Use of Gene Expression Analysis in Healthcare Institutions and Hospitals
5.4 Gene Expression Analysis Market Segmentation
5.4.1 By Technology
18.104.22.168 Polymerase Chain Reaction (PCR)
22.214.171.124 Next Generation Sequencing (NGS)
126.96.36.199 Sanger Sequencing
5.4.2 By Usage
5.4.3 By Application
188.8.131.52 Drug Discovery
184.108.40.206 Academic Laboratories
220.127.116.11 Diagnostic Laboratories
5.4.4 By Geography
18.104.22.168 Middle East & North Africa (MENA)
22.214.171.124 North America
126.96.36.199 Rest of the World
6. Industry Analysis
6.1 Key Trends and Developments
6.2 Investment Analysis
6.3 PorterFive Forces
6.3.1 Bargaining Power of Suppliers
6.3.2 Bargaining Power of Consumers
6.3.3 Threat of New Entrants
6.3.4 Threat of Substitute Products and Services
6.3.5 Competitive Rivalry within the Industry
7. Competitive Landscape
7.1 Key Market Players
7.1.1 Agilent Technologies
188.8.131.52 Agilent Technologies- Business Overview
184.108.40.206 Agilent Technologies- Product and Services Portfolio
220.127.116.11 Agilent Technologies- Deals Landscape
18.104.22.168 Agilent Technologies- SWOT Analysis
7.1.2 Bio-Rad Laboratories
7.1.3 GE Healthcare
7.1.4 Life Technologies
7.1.7 Roche Diagnostics
7.2 Merger and Acquisition Analysis
7.3 New Product Launches
7.4 Agreements, Collaborations & Partnerships
8. Analyst Outlook for Investment Opportunities
9. Future Outlook of the Market